Related Experiment Video
Updated: Jun 1, 2026

Isolation, Enrichment, and Maintenance of Medulloblastoma Stem Cells
Published on: September 1, 2010
Hedgehog pathway activity in pediatric embryonal rhabdomyosarcoma and undifferentiated sarcoma: a report from the
Joseph G Pressey1, James R Anderson, David K Crossman
1Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA. jpressey@uab.edu
Background:
Aberrant activation of the hedgehog (Hh) signaling pathway is implicated widely in both pediatric and adult malignancies. Inactivation of the Hh regulator PTCH is responsible for the Gorlin cancer predisposition syndrome. The spectrum of tumors found in Gorlin Syndrome includes basal cell carcinoma, medulloblastoma, and rarely, rhabdomyosarcoma (RMS). A previous report utilizing in situ hybridization has provided initial evidence for the expression of Hh targets GLI1 and PTCH in RMS tumors.
Procedure:
To investigate the role of Hh pathway signaling in pediatric RMS and undifferentiated sarcoma (US) tumors, the expression of Hh pathway targets GLI1 and PTCH was measured. RNA was extracted from archival human tumor specimens collected from pediatric patients enrolled on Intergroup Rhabdomyosarcoma Study III and IV, and subjected to quantitative reverse transcriptase-polymerase chain reaction.
Results:
Expression of GLI1 with or without PTCH was detected in substantial subsets of embryonal RMS (ERMS) and US tumors but only rarely in alveolar RMS tumors. Neither PTCH mutations nor activating SMO mutations were detected in ERMS tumors with high GLI1 expression. Microarray analysis demonstrated relative overexpression of downstream Hh targets in ERMS tumors with high or intermediate GLI1 expression. Unlike a recent report, Hh pathway activity in ERMS tumors did not correlate with a unique clinical phenotype.
Conclusions:
Our findings support a role for Hh pathway activation in the genesis of a subset of ERMS and US tumors. Hh signaling may represent a novel therapeutic target in affected tumors.
Insights
Aberrant hedgehog (Hh) signaling is active in some pediatric rhabdomyosarcoma (RMS) and undifferentiated sarcoma (US) tumors. This pathway may be a new therapeutic target for these cancers.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Genetics
Background:
- Aberrant activation of the hedgehog (Hh) signaling pathway is implicated in numerous pediatric and adult malignancies.
- Inactivation of the Hh regulator PTCH causes Gorlin syndrome, a cancer predisposition syndrome.
- Hh pathway targets GLI1 and PTCH have shown initial evidence of expression in rhabdomyosarcoma (RMS) tumors.
Purpose of the Study:
- To investigate the role of Hh pathway signaling in pediatric RMS and undifferentiated sarcoma (US) tumors.
- To measure the expression of Hh pathway targets GLI1 and PTCH in these pediatric tumors.
Main Methods:
- RNA extraction from archival human tumor specimens from pediatric patients.
- Quantitative reverse transcriptase-polymerase chain reaction (qRT-PCR) to measure GLI1 and PTCH expression.
- Microarray analysis to assess downstream Hh target gene expression.
Main Results:
- GLI1 and/or PTCH expression was detected in significant subsets of embryonal RMS (ERMS) and US tumors, but rarely in alveolar RMS.
- No PTCH or SMO mutations were found in ERMS tumors with high GLI1 expression.
- Microarray analysis revealed overexpression of downstream Hh targets in ERMS tumors with high or intermediate GLI1 expression.
Conclusions:
- Findings support a role for Hh pathway activation in the development of a subset of ERMS and US tumors.
- Hedgehog signaling represents a potential novel therapeutic target for these specific pediatric sarcomas.
Related Concept Videos
Hedgehog Signaling Pathway
Hedgehog Signaling Pathway
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
